Letter to the Editor
The PARADIGM-HF population may be very different from real-world heart failure patients
A população do PARADIGM-HF pode ser muito diferente do mundo real dos pacientes com insuficiência cardíaca
Lido
3866
Vezesque se leu este artigo
1601
Total PDF
2265
Total HTML
Compartilhar estatísticas
array:25 [ "pii" => "S0870255118304931" "issn" => "08702551" "doi" => "10.1016/j.repc.2018.08.006" "estado" => "S300" "fechaPublicacion" => "2019-02-01" "aid" => "1349" "copyright" => "Sociedade Portuguesa de Cardiologia" "copyrightAnyo" => "2019" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Rev Port Cardiol. 2019;38:163" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 800 "formatos" => array:3 [ "EPUB" => 106 "HTML" => 484 "PDF" => 210 ] ] "Traduccion" => array:1 [ "en" => array:20 [ "pii" => "S2174204919300650" "issn" => "21742049" "doi" => "10.1016/j.repce.2019.03.005" "estado" => "S300" "fechaPublicacion" => "2019-02-01" "aid" => "1349" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Rev Port Cardiol. 2019;38:163" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 426 "formatos" => array:3 [ "EPUB" => 58 "HTML" => 245 "PDF" => 123 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "The PARADIGM-HF population may be very different from real-world heart failure patients" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "163" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "A população do PARADIGM-HF pode ser muito diferente do mundo real dos pacientes com insuficiência cardíaca" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Walter Calderón-Gerstein" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Walter" "apellidos" => "Calderón-Gerstein" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0870255118304931" "doi" => "10.1016/j.repc.2018.08.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255118304931?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204919300650?idApp=UINPBA00004E" "url" => "/21742049/0000003800000002/v1_201904100624/S2174204919300650/v1_201904100624/en/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S0870255119301015" "issn" => "08702551" "doi" => "10.1016/j.repc.2019.02.001" "estado" => "S300" "fechaPublicacion" => "2019-02-01" "aid" => "1350" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Rev Port Cardiol. 2019;38:165" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 937 "formatos" => array:3 [ "EPUB" => 70 "HTML" => 659 "PDF" => 208 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Response to the Letter to the Editor – “The PARADIGM-HF population may be very different from real-world heart failure patients”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "165" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Resposta à Carta ao Editor «A população do PARADIGM-HF pode ser muito diferente do mundo real dos doentes com insuficiência cardíaca»" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Gustavo Rodrigues, António Tralhão, Carlos Aguiar, Pedro Freitas, António Ventosa, Miguel Mendes" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Gustavo" "apellidos" => "Rodrigues" ] 1 => array:2 [ "nombre" => "António" "apellidos" => "Tralhão" ] 2 => array:2 [ "nombre" => "Carlos" "apellidos" => "Aguiar" ] 3 => array:2 [ "nombre" => "Pedro" "apellidos" => "Freitas" ] 4 => array:2 [ "nombre" => "António" "apellidos" => "Ventosa" ] 5 => array:2 [ "nombre" => "Miguel" "apellidos" => "Mendes" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255119301015?idApp=UINPBA00004E" "url" => "/08702551/0000003800000002/v6_201912041757/S0870255119301015/v6_201912041757/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S0870255117305310" "issn" => "08702551" "doi" => "10.1016/j.repc.2017.08.011" "estado" => "S300" "fechaPublicacion" => "2019-02-01" "aid" => "1260" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "sco" "cita" => "Rev Port Cardiol. 2019;38:161-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1010 "formatos" => array:3 [ "EPUB" => 81 "HTML" => 684 "PDF" => 245 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Image in Cardiology</span>" "titulo" => "Acute myocardial infarction complicated with cardiogenic shock as a late onset of Kawasaki disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "161" "paginaFinal" => "162" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Enfarte agudo do miocárdio complicado por choque cardiogénico devido a início tardio da doença de Kawasaki" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 965 "Ancho" => 2167 "Tamanyo" => 201822 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Right coronary angiogram.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">(A) Calcified giant aneurysm of the right coronary artery is easier to see on the fluoroscopy; (B) total thrombotic occlusion of the proximal right coronary artery.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rocío González Ferreiro, Diego López Otero, Alfredo Redondo Diéguez, José Luis Martínez Sande, Ramiro Trillo Nouche, José Ramón González Juanatey" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Rocío González" "apellidos" => "Ferreiro" ] 1 => array:2 [ "nombre" => "Diego López" "apellidos" => "Otero" ] 2 => array:2 [ "nombre" => "Alfredo Redondo" "apellidos" => "Diéguez" ] 3 => array:2 [ "nombre" => "José Luis Martínez" "apellidos" => "Sande" ] 4 => array:2 [ "nombre" => "Ramiro Trillo" "apellidos" => "Nouche" ] 5 => array:2 [ "nombre" => "José Ramón González" "apellidos" => "Juanatey" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2174204919300637" "doi" => "10.1016/j.repce.2017.08.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204919300637?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255117305310?idApp=UINPBA00004E" "url" => "/08702551/0000003800000002/v6_201912041757/S0870255117305310/v6_201912041757/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "The PARADIGM-HF population may be very different from real-world heart failure patients" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "163" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Walter Calderón-Gerstein" "autores" => array:1 [ 0 => array:3 [ "nombre" => "Walter" "apellidos" => "Calderón-Gerstein" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Hospital Nacional “Ramiro Prialé Prialé”, Internal Medicine Service, Huancayo, Essalud, Peru" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Univesidad Continental, Huancayo, Peru" "etiqueta" => "b" "identificador" => "aff0010" ] ] ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "A população do PARADIGM-HF pode ser muito diferente do mundo real dos pacientes com insuficiência cardíaca" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleSmallCaps">I</span> have read with great interest the article by Rodrigues et al.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">1</span></a> and the editorial comment<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">2</span></a> about the use of sacubitril/valsartan in patients with systolic heart failure, and <span class="elsevierStyleSmallCaps">I</span> share the same concerns about the target population of this drug.</p><p id="par0010" class="elsevierStylePara elsevierViewall">In an epidemiological study in Lima, Peru,<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">3</span></a> of 1075 patients with heart failure, 46% had normal ejection fraction and only 39% had heart failure with reduced ejection fraction (≤40%) (HFrEF). Overall, 30% of patients with heart failure also had chronic renal disease, leaving only 20-25% of patients eligible for treatment with sacubitril/valsartan.</p><p id="par0015" class="elsevierStylePara elsevierViewall">In a high-altitude population like Huancayo (3250 meters above sea level), the profile of heart failure patients is even more dissimilar,<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">4</span></a> with 89.9% of patients having a normal ejection fraction, while around 25% of individuals have heart failure and chronic lung disease, leaving only 2.2% of patients eligible for this drug.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Another concern is about how many patients will tolerate the target dose of 97/103<span class="elsevierStyleHsp" style=""></span>mg, because as Antol et al.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">5</span></a> pointed out, only 17.4% of patients in their retrospective study could achieve this goal. Despite this result, the hospitalization rate, symptoms and weight gain decreased in those who were treated with sacubitril/valsartan.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In search of an answer about the profile of patients who will benefit from sacubitril/valsartan, the PARAGON-HF trial<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">6</span></a> is currently under way and will try to determine if the drug is useful for patients with preserved ejection fraction (HFpEF). Caution must be exercised because drugs used for HFrEF that showed promise for HFpEF did not improve prognosis for this condition when tested in large clinical trials.<a class="elsevierStyleCrossRefs" href="#bib0080"><span class="elsevierStyleSup">7–9</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">As Ricardo Fontes-Carvalho pointed out in his editorial comment,<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">2</span></a> we must recognize that sacubitril/valsartan is an important advance for heart failure therapy, even though its benefits have not been proved in a broader, real-world heart failure population. Taking this into account, new drugs are needed for patients with heart failure who have chronic renal or pulmonary conditions or have normal or intermediate ejection fraction.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of interest</span><p id="par0035" class="elsevierStylePara elsevierViewall">The author has no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:9 [ 0 => array:3 [ "identificador" => "bib0050" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Será a coorte do PARADIGM-HF representativa da população do mundo real de doentes com insuficiência cardíaca?" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "G. Rodrigues" 1 => "A. Tralhão" 2 => "C. Aguiar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.repc.2017.09.023" "Revista" => array:6 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "2018" "volumen" => "37" "paginaInicial" => "491" "paginaFinal" => "496" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29779951" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0055" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sacubitril-valsartan in the real world: from theory to clinical practice" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Fontes-Carvalho" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.repc.2018.04.008" "Revista" => array:6 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "2018" "volumen" => "37" "paginaInicial" => "497" "paginaFinal" => "498" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29801712" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0060" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiological clinical characteristics of acute cardiac insufficiency in a tertiary hospital in Lima, Perú" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Pariona" 1 => "P. Segura Saldaña" 2 => "M. Padilla Reyes" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.17843/rpmesp.2017.344.2890" "Revista" => array:6 [ "tituloSerie" => "Rev Peru Med Exp Salud Pública" "fecha" => "2017" "volumen" => "34" "paginaInicial" => "655" "paginaFinal" => "659" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29364406" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0065" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diastolic heart failure: most common type of heart insufficiency in high-altitude residents" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "W. Calderón" 1 => "O. Contreras" 2 => "V. Munive" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Soc Per Med Int" "fecha" => "2006" "volumen" => "19" "paginaInicial" => "19" "paginaFinal" => "26" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0070" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An early view of real-world patient response to sacubitril/valsartan: a retrospective study of patients with heart failure with reduced ejection fraction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D. Antol" 1 => "A. Casebeer" 2 => "R. DeClue" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12325-018-0710-4" "Revista" => array:6 [ "tituloSerie" => "Adv Ther" "fecha" => "2018" "volumen" => "35" "paginaInicial" => "785" "paginaFinal" => "795" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29777521" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0075" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sacubitril/valsartan: from clinical trials to real-world experience" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Joly" 1 => "A. Desai" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11936-018-0638-7" "Revista" => array:5 [ "tituloSerie" => "Curr Treat Options Cardiovasc Med" "fecha" => "2018" "volumen" => "20" "paginaInicial" => "45" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29687191" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0080" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Irbesartan in patients with heart failure and preserved ejection fraction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "B. Massie" 1 => "P. Carson" 2 => "J. McMurray" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa0805450" "Revista" => array:7 [ "tituloSerie" => "N Engl J Med" "fecha" => "2008" "volumen" => "359" "paginaInicial" => "2456" "paginaFinal" => "2467" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19001508" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0168827810000978" "estado" => "S300" "issn" => "01688278" ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0085" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "K. Yamamoto" 1 => "H. Origasa" 2 => "M. Hori" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurjhf/hfs141" "Revista" => array:6 [ "tituloSerie" => "Eur J Heart Fail" "fecha" => "2013" "volumen" => "15" "paginaInicial" => "110" "paginaFinal" => "118" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22983988" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0090" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Therapy for heart failure with preserved ejection fraction: current status, unique challenges, and future directions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B. Upadhya" 1 => "M.J. Haykowsky" 2 => "D.W. Kitzman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10741-018-9714-z" "Revista" => array:2 [ "tituloSerie" => "Heart Fail Rev" "fecha" => "2018" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/08702551/0000003800000002/v6_201912041757/S0870255118304931/v6_201912041757/en/main.assets" "Apartado" => array:4 [ "identificador" => "29267" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Cartas ao Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/08702551/0000003800000002/v6_201912041757/S0870255118304931/v6_201912041757/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255118304931?idApp=UINPBA00004E" ]
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2024 Novembro | 9 | 6 | 15 |
| 2024 Outubro | 33 | 26 | 59 |
| 2024 Setembro | 42 | 27 | 69 |
| 2024 Agosto | 53 | 35 | 88 |
| 2024 Julho | 45 | 34 | 79 |
| 2024 Junho | 49 | 24 | 73 |
| 2024 Maio | 32 | 16 | 48 |
| 2024 Abril | 30 | 26 | 56 |
| 2024 Maro | 50 | 27 | 77 |
| 2024 Fevereiro | 42 | 17 | 59 |
| 2024 Janeiro | 28 | 30 | 58 |
| 2023 Dezembro | 23 | 21 | 44 |
| 2023 Novembro | 33 | 28 | 61 |
| 2023 Outubro | 18 | 11 | 29 |
| 2023 Setembro | 23 | 18 | 41 |
| 2023 Agosto | 23 | 18 | 41 |
| 2023 Julho | 27 | 12 | 39 |
| 2023 Junho | 25 | 17 | 42 |
| 2023 Maio | 27 | 27 | 54 |
| 2023 Abril | 19 | 2 | 21 |
| 2023 Maro | 36 | 22 | 58 |
| 2023 Fevereiro | 19 | 25 | 44 |
| 2023 Janeiro | 15 | 16 | 31 |
| 2022 Dezembro | 36 | 20 | 56 |
| 2022 Novembro | 33 | 27 | 60 |
| 2022 Outubro | 29 | 26 | 55 |
| 2022 Setembro | 24 | 33 | 57 |
| 2022 Agosto | 19 | 27 | 46 |
| 2022 Julho | 31 | 47 | 78 |
| 2022 Junho | 22 | 28 | 50 |
| 2022 Maio | 30 | 34 | 64 |
| 2022 Abril | 24 | 37 | 61 |
| 2022 Maro | 35 | 38 | 73 |
| 2022 Fevereiro | 27 | 38 | 65 |
| 2022 Janeiro | 27 | 21 | 48 |
| 2021 Dezembro | 28 | 33 | 61 |
| 2021 Novembro | 31 | 41 | 72 |
| 2021 Outubro | 45 | 49 | 94 |
| 2021 Setembro | 37 | 30 | 67 |
| 2021 Agosto | 36 | 45 | 81 |
| 2021 Julho | 28 | 25 | 53 |
| 2021 Junho | 29 | 24 | 53 |
| 2021 Maio | 40 | 37 | 77 |
| 2021 Abril | 39 | 67 | 106 |
| 2021 Maro | 51 | 13 | 64 |
| 2021 Fevereiro | 52 | 14 | 66 |
| 2021 Janeiro | 50 | 21 | 71 |
| 2020 Dezembro | 46 | 10 | 56 |
| 2020 Novembro | 40 | 21 | 61 |
| 2020 Outubro | 22 | 15 | 37 |
| 2020 Setembro | 22 | 8 | 30 |
| 2020 Agosto | 20 | 5 | 25 |
| 2020 Julho | 31 | 13 | 44 |
| 2020 Junho | 35 | 7 | 42 |
| 2020 Maio | 17 | 10 | 27 |
| 2020 Abril | 7 | 20 | 27 |
| 2020 Maro | 26 | 17 | 43 |
| 2020 Fevereiro | 92 | 23 | 115 |
| 2020 Janeiro | 47 | 10 | 57 |
| 2019 Dezembro | 35 | 10 | 45 |
| 2019 Novembro | 23 | 9 | 32 |
| 2019 Outubro | 38 | 4 | 42 |
| 2019 Setembro | 38 | 11 | 49 |
| 2019 Agosto | 20 | 10 | 30 |
| 2019 Julho | 22 | 12 | 34 |
| 2019 Junho | 51 | 37 | 88 |
| 2019 Maio | 41 | 21 | 62 |
| 2019 Abril | 66 | 42 | 108 |
| 2019 Maro | 22 | 26 | 48 |
Mostrar tudo
